Report Detail
Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019
- RnM3864409 |
- 10 January, 2020 |
- Global |
- 128 Pages |
- GlobalData |
- Medical Devices & Consumables
Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019" provides an overview of Tissue Heart Valves currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Heart Valves pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Tissue Heart Valves under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Heart Valves under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 5
- 1.2 List of Figures 7
2 Introduction 8
- 2.1 Tissue Heart Valves Overview 8
3 Products under Development 9
- 3.1 Tissue Heart Valves - Pipeline Products by Stage of Development 9
- 3.2 Tissue Heart Valves - Pipeline Products by Segment 10
- 3.3 Tissue Heart Valves - Pipeline Products by Territory 11
- 3.4 Tissue Heart Valves - Pipeline Products by Regulatory Path 12
- 3.5 Tissue Heart Valves - Pipeline Products by Estimated Approval Date 13
- 3.6 Tissue Heart Valves - Ongoing Clinical Trials 14
4 Tissue Heart Valves - Pipeline Products under Development by Companies 15
- 4.1 Tissue Heart Valves Companies - Pipeline Products by Stage of Development 15
- 4.2 Tissue Heart Valves - Pipeline Products by Stage of Development 16
5 Tissue Heart Valves Companies and Product Overview 18
- 5.1 Abbott Vascular Inc Company Overview 18
- 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 18
- 5.2 Children's Hospital Boston Company Overview 21
- 5.2.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21
- 5.3 Colibri Heart Valve LLC Company Overview 22
- 5.3.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 22
- 5.4 CorMatrix Cardiovascular Inc Company Overview 24
- 5.4.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 24
- 5.5 CroiValve Ltd Company Overview 29
- 5.5.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
- 5.6 CryoLife Inc Company Overview 30
- 5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 30
- 5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 32
- 5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32
- 5.8 Daidalos Solutions BV Company Overview 33
- 5.8.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 33
- 5.9 Edwards Lifesciences Corp Company Overview 36
- 5.9.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 36
- 5.10 Hancock Jaffe Laboratories Inc Company Overview 42
- 5.10.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 42
- 5.11 LivaNova PLC Company Overview 44
- 5.11.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 44
- 5.12 Medtronic plc Company Overview 49
- 5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 49
- 5.13 Revivicor Inc Company Overview 51
- 5.13.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 51
- 5.14 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 52
- 5.14.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 52
- 5.15 Stellenbosch University Company Overview 53
- 5.15.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 53
- 5.16 Tissue Regenix Ltd Company Overview 54
- 5.16.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
- 5.17 University of California Irvine Company Overview 56
- 5.17.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 56
- 5.18 University of Cambridge Company Overview 58
- 5.18.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 58
- 5.19 University of Minnesota Company Overview 59
- 5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 59
- 5.20 University of Zurich Company Overview 60
- 5.20.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 60
- 5.21 Valcare Medical Company Overview 61
- 5.21.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 61
- 5.22 ValveXchange, Inc. (Inactive) Company Overview 62
- 5.22.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62
- 5.23 VueKlar Cardiovascular Ltd (Inactive) Company Overview 65
- 5.23.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65
6 Tissue Heart Valves- Recent Developments 66
- 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 66
- 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 68
- 6.3 Oct 30, 2019: OmniGuide Holdings hires Giorgio Brusa as VP Global Marketing and Matthew Rice as Managing Director, OmniGuide Surgical Strategic Business Unit 69
- 6.4 Oct 30, 2019: LivaNova reports third quarter 2019 results 70
- 6.5 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 71
7 Appendix 125
- 7.1 Methodology 125
- 7.2 About GlobalData 128
- 7.3 Contact Us 128
Summary:
Get latest Market Research Reports on Tissue Heart Valves. Industry analysis & Market Report on Tissue Heart Valves is a syndicated market report, published as Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Tissue Heart Valves market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
